Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andreas Meisel

Showing results (291-300 of 311) with videos related to

Pageof 32
Sort By:
European Journal of Neurology|April 15, 2026
Complement Inhibition Therapy in Myasthenic Crisis-A Multicentre Retrospective Analysis of 17 Cases From GermanyLea Gerischer, Maike Stein, Alice Schneider, et al.
Neurological Research and Practice|May 13, 2026
Multicentric prognostic observational study on biomarker profile in immunotherapy-naïve patients with highly active generalized myasthenia gravis (PROGNO-MG): a study protocolFelix Kohle, Franz Felix Konen, Ulrike Grittner, et al.
Therapeutic Advances in Neurological Disorders|December 28, 2023
Guideline for the management of myasthenic syndromesHeinz Wiendl, Angela Abicht, Andrew Chan, et al.
Journal of Neurology|November 4, 2023
Weaning and extubation failure in myasthenic crisis: a multicenter analysisBernhard Neumann, Klemens Angstwurm, Christian Dohmen, et al.
Orphanet Journal of Rare Diseases|May 12, 2017
Sporadic late-onset nemaline myopathy: clinico-pathological characteristics and review of 76 casesLukas J Schnitzler, Tobias Schreckenbach, Aleksandra Nadaj-Pakleza, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|December 8, 2025
Assessing post-stroke cognition in pre-clinical models: Lessons and recommendations from a multi-center studyGaia Brezzo, Kristy A Zera, Dana E Straus, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|January 11, 2025
C5 complement inhibition versus FcRn modulation in generalised myasthenia gravisNiklas Huntemann, Lea Gerischer, Meret Herdick, et al.
Journal of Neurology|July 11, 2024
Preventing long-term disability in CIDP: the role of timely diagnosis and treatment monitoring in a multicenter CIDP cohortPaula Quint, Christina B Schroeter, Felix Kohle, et al.
Acta Neuropathologica|June 18, 2024
Inter-alpha-trypsin inhibitor heavy chain H3 is a potential biomarker for disease activity in myasthenia gravisChristina B Schroeter, Christopher Nelke, Frauke Stascheit, et al.
Journal of Neurology|April 7, 2022
Seronegative myasthenic crisis: a multicenter analysisPhilipp Mergenthaler, Henning R Stetefeld, Christian Dohmen, et al.
Pageof 32

Showing results (291-300 of 311) with videos related to

Sort By:
Pageof 32
European Journal of Neurology|April 15, 2026
Complement Inhibition Therapy in Myasthenic Crisis-A Multicentre Retrospective Analysis of 17 Cases From GermanyLea Gerischer, Maike Stein, Alice Schneider, et al.
Neurological Research and Practice|May 13, 2026
Multicentric prognostic observational study on biomarker profile in immunotherapy-naïve patients with highly active generalized myasthenia gravis (PROGNO-MG): a study protocolFelix Kohle, Franz Felix Konen, Ulrike Grittner, et al.
Therapeutic Advances in Neurological Disorders|December 28, 2023
Guideline for the management of myasthenic syndromesHeinz Wiendl, Angela Abicht, Andrew Chan, et al.
Journal of Neurology|November 4, 2023
Weaning and extubation failure in myasthenic crisis: a multicenter analysisBernhard Neumann, Klemens Angstwurm, Christian Dohmen, et al.
Orphanet Journal of Rare Diseases|May 12, 2017
Sporadic late-onset nemaline myopathy: clinico-pathological characteristics and review of 76 casesLukas J Schnitzler, Tobias Schreckenbach, Aleksandra Nadaj-Pakleza, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|December 8, 2025
Assessing post-stroke cognition in pre-clinical models: Lessons and recommendations from a multi-center studyGaia Brezzo, Kristy A Zera, Dana E Straus, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|January 11, 2025
C5 complement inhibition versus FcRn modulation in generalised myasthenia gravisNiklas Huntemann, Lea Gerischer, Meret Herdick, et al.
Journal of Neurology|July 11, 2024
Preventing long-term disability in CIDP: the role of timely diagnosis and treatment monitoring in a multicenter CIDP cohortPaula Quint, Christina B Schroeter, Felix Kohle, et al.
Acta Neuropathologica|June 18, 2024
Inter-alpha-trypsin inhibitor heavy chain H3 is a potential biomarker for disease activity in myasthenia gravisChristina B Schroeter, Christopher Nelke, Frauke Stascheit, et al.
Journal of Neurology|April 7, 2022
Seronegative myasthenic crisis: a multicenter analysisPhilipp Mergenthaler, Henning R Stetefeld, Christian Dohmen, et al.
Pageof 32